Dr. White received his medical degree from the Medical College of Georgia. He completed his residency at the University of Connecticut School of Medicine and a fellowship at the University of Bergen, Norway. Dr. White is the author of 300 publications in peer-reviewed journals and book chapters in the area of clinical hypertension, pharmacology, and vascular diseases. He is also author of three medical textbooks in hypertension and ambulatory blood pressure monitoring, editor of the journal Blood Pressure Monitoring and a member of eight editorial boards for cardiovascular journals. Clinical Interests: Dr. White is lead physician for the hypertension and vascular diseases in the UConn Health Center's Pat and Jim Calhoun Cardiology Center and has served as consulting physician in hypertension and vascular diseases at St. Francis Hospital and Medical Center in Hartford. The practice sees all types of patients, over 15 years old, with hypertension and complications, including secondary, resistant, and severe forms of the disease. Research Interests: We have a longstanding interest in clinical hypertension and pharmcology, particularly in the areas of ambulatory blood pressure monitoring, clinical trials of antihypertensive drugs, and the impact of non-cardiac drugs (e.g., NSAIDs, neuropsychiatric agents, analgesics) in cardiovascular disorders. During the past decade, Dr. White has also developed expertise in the cardiovascular safety of non-cardiac drugs and has published several articles on the effects of agents on blood pressure, renal function, microvascular disease of the brain, and cardiovascular outcomes. Dr. White has extensive experience as chair of data safety monitoring boards, cardiovascular endpoint committees, and interacting with the Food and Drug administration as a cardiovascular safety consultant. The division of hypertension and clinical pharmacology has received several million dollars in research funding from the National Institutes of Health, the American Heart Association, the Donaghue Research Foundation, and the pharmaceutical industry. Selected Publications: Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research Consortium. Sager, Philip T; Seltzer, Jonathan; Turner, J Rick; Anderson, Jeffrey L; Hiatt, William R; Kowey, Peter; Prochaska, Judith J; Stockbridge, Norman; White, William B. (2015). American heart journal, 4, (169), 486-495. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Zannad, Faiez; Cannon, Christopher P; Cushman, William C; Bakris, George L; Menon, Venu; Perez, Alfonso T; Fleck, Penny R; Mehta, Cyrus R; Kupfer, Stuart; Wilson, Craig; Lam, Hung; White, William B. (2015). Lancet, Foreword. The 20th year of Blood Pressure Monitoring. White, William B. (2015). Blood pressure monitoring, 1, (20), 1. Exposure to Racial Discrimination and Ambulatory Blood Pressure in Women with Type 2 Diabetes. Wagner, Julie; Tennen, Howard; Finan, Patrick; Feinn, Richard; Burg, Matthew M; Seawell, Asani; White, William B. (2015). Stress and health : journal of the International Society for the Investigation of Stress, Managing hypertension with ambulatory blood pressure monitoring. White, William B; Gulati, Vinay. (2015). Current cardiology reports, 2, (17), 2.